WP4 - Adrenal cancer genomics platform
Objectives
- Establishment of molecular predictors of malignancy and outcome of ACC and treatment response in ADIUVO patients.
- Identification of biomarkers associated with malignant behaviour and clinical outcome, in both archival MPH material and FIRSTMAPPP trial patients.
WP Leader
Prof. Jérôme Bertherat, 
Institut National de la Santé et de la Recherche Médicale
WP Partners
Ludwig-Maximilians-University Munich
Erasmus University Medical Center Rotterdam
Fundacion Centro Nacional de Investigaciones Oncologicas Carlos III
